Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same

Modulation of huntingtin expression

LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA

METHOD FOR PREDICTING DEVELOPMENT OF MELANOMA BRAIN METASTASIS

C/EBPα short activating RNA compositions and methods of use

MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1

Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer

USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS

Reversible platelet inhibition

Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG

Modulation of T cell signaling threshold and T cell sensitivity to antigens

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3

Methods and compositions employing an osteopontin aptamer to deliver nucleic acids into smooth muscle, endothelial, cardiac and progenitor/stem cells

Targeting microRNA-26a/b for the treatment of neurodegenerative disease

Inhibition of a lncRNA for treatment of melanoma

Treating hepatitis virus infection by modulating microRNAs miR-130a, miR-130b, miR-204, or miR-1236

MicroRNA compounds and methods for modulating miR-122

MicroRNAs modulating the effect of glucocorticoid signaling

Reducing intron retention

TARGETING GLIOMA STEM CELLS BY SEQUENCE-SPECIFIC FUNCTIONAL INHIBITION OF PRO-SURVIVAL ONCOMIR-138

TREATING DISEASES ASSOCIATED WITH PGC1-ALPHA BY MODULATING MICRORNAS MIR-130A AND MIR-130B

Microrna inhibition for the treatment of inflammation and myeloproliferative disorders

MicroRNA compounds and methods for modulating miR-21 activity

Method for the inhibition of angiogenesis

METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

Methods and pharmaceutical compositions for treatment of cystic fibrosis

NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE

Identification of small molecules that facilitate therapeutic exon skipping

Targeting microRNAs for metabolic disorders

miR-92 inhibitors and uses thereof

AAV-based treatment of cholesterol-related disorders

Therapeutic agent for corneal epithelial disorder

USE OF NUCLEIC ACIDS WITH REDUCED PRESSURE THERAPY

Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration

Methods for Diagnosing Lung Cancer Using MicroRNAs

AGENTS AND METHODS FOR INHIBITING MIR-148A FOR THE MODULATION OF CHOLESTEROL LEVELS

Synthetic nanostructures including nucleic acids and/or other entities

Methods of Inhibiting Tumorigenesis in Colon Adenocarcinoma and Compositions Therefor

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Sphingolipid-polyalkylamine-oligonucleotide compounds

Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)

Methods and compositions using miR-3151 in the diagnosis and treatment of thyroid cancer

Detection and treatment of irritable bowel syndrome

Methods and compositions involving lincRNA and leukemia

Oligomers with improved off-target profile

Albumin production and cell proliferation

Inhibition of microRNA for treatment of sepsis

Double-stranded agents for delivering therapeutic oligonucleotides

DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS

Micro-RNA family that modulates fibrosis and uses thereof

Micro-RNA family that modulates fibrosis and uses thereof

Micro-RNA family that modulates fibrosis and uses thereof

Dosage compensating transgenes and cells

Compositions, kits and methods for treatment of cardiovascular,immunological and inflammatory diseases

Methods for detecting and treating multiple myeloma

Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF

Anti-miR-27b and anti-miR-148a oligonucleotides as therapeutic tools for treating dyslipidemias and cardiovascular diseases

Microrna compounds and methods for modulating MIR-21 activity

Antisense oligonucleotides for treatment of cancer stem cells

Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA

Targeting microRNAs for the treatment of fibrosis

NEUROTENSIN-INDUCED TUMOR FORMATION IS REGULATED BY MICRO RNA 133A-AFTIPHILIN-DEPENDENT RECEPTOR RECYCLING

Compositions and methods for modulating apolipoprotein (a) expression

Compositions and methods for modulating apolipoprotein C-III expression

Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism

Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same

Compositions and methods

Compositions and methods for modulating HBV expression

miR-29 mimics and uses thereof

MICRO-RNAS MODULATING IMMUNITY AND INFLAMMATION

Kit with stabilized thrombin

Materials and Methods Useful For Affecting Tumor Cell Growth, Migration and Invasion

Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG

Targeting microRNAs for the treatment of liver cancer

Targeting microRNAs for metabolic disorders

Methods for enhancing utrophin production via inhibition of microRNA

DNAI FOR THE MODULATION OF GENES

Modulation of RNA activity and vascular permeability

Oral delivery of therapeutically effective LNA oligonucleotides

Recombinant polypeptide production

Methods for monitoring C9ORF72 expression

Targeting microRNA miR-409-3P to treat prostate cancer

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Reducing intron retention

Locked nucleic acid inhibitor of miR-145 and uses thereof

Bridged bicyclic nucleosides

Method for treating and/or preventing myopia

Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1

METHODS AND COMPOSITIONS FOR MANAGING VASCULAR CONDITIONS

Modified oligonucleotides for telomerase inhibition

Segmented micro RNA mimetics

Treatment of neuropathic pain

COMPOSITIONS AND METHODS OF INHIBITING GENE EXPRESSION IN A LUNG

LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES

Inhibitors of miRNAs 221 and 222 for anti-tumor activity in multiple myeloma

COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR

Oligonucleotide compositions and methods of making the same

Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Modified oligonucleotides for telomerase inhibition

Modified oligonucleotides for telomerase inhibition

Deep intronic target for splicing correction on spinal muscular atrophy gene

Methods for treatment of alport syndrome

CIRCULAR RNA FOR INHIBITION OF MICRORNA

Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor

MICROMIRs

Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway

Extraction, preparation, and application of plant micro-ribonucleic acid

Method of promoting wound healing

Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)

Methods and compositions for use in treatment of FOXP2-related cancers

THY1 (CD90) as a novel therapy to control adipose tissue accumulation

MiRNAs as novel therapeutic targets and diagnostic biomarkers for parkinsons disease

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2

Use of miR-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects

Use of miR-494 to modulate TRAIL-induced apoptosis through BIM down-regulation

Pharmaceutical composition comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-202-5P inhibitor for inhibiting cancer

Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3)

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)

METHODS FOR SELECTIVE TARGETING OF HETEROCHROMATIN FORMING NON-CODING RNA

Methods and compositions using miR-3151 in the diagnosis and treatment of cancer

Selective reactivation of genes on the inactive X chromosome

MicroRNA compounds and methods for modulating miR-21 activity

Compositions and methods for treating peripheral arterial disease

Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP

Agent for treating cancer

Ligand-conjugated monomers

Modulation of UBE3A-ATS expression

Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy

Recombinant DNA constructs and methods for controlling gene expression

Methods of inducing insulin production

Modulation of enhancer RNA mediated gene expression

TREATMENT OF SIALIDASE 4 (NEU4) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NEU4

Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG

Compositions and methods for inhibition of nucleic acids function

Modulation of huntingtin expression

Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4

Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3

DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS

Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF

Compound and method for treating myotonic dystrophy

Therapeutic micro RNA targets in chronic pulmonary diseases

Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG

Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1

Manipulating microRNA for the management of neurological diseases or conditions and compositions related thereto

Inhibitors of microRNAs that regulate production of atrial natriuretic peptide (ANP) as therapeutics and uses thereof

Compositions and methods for modulating apolipoprotein (a) expression

Compositions and methods for modulating apolipoprotein C-III expression

Conjugated antisense compounds and their use

Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63

Micro-RNA inhibitors and their uses in disease

Method of reducing the number of EMT and MET type breast cancer stem cells

Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8

Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders

Methods and compositions for modulating MIR-204 activity

Treatment of cancers with micro-RNA inhibitors

Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

MicroRNA compounds and methods for modulating miR-122

Small activating RNA molecules and methods of use

Compositions and methods for gene silencing

OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family

Compositions And Methods For Inhibiting Expression Of CD45 Gene

Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

Micro-RNAs involved in macular degeneration

Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1

Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3

Targeting micrornas for the treatment of fibrosis

MicroRNA Treatment for Asthma

Micro-RMA inhibitor

Methods for the treatment of nonalcoholic steatohepatitis

Trans-acting RNA switches

Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1

Targeting MicroRNAs for metabolic disorders

Methods of modulating smooth muscle cell proliferation and differentiation

Compositions and methods for treatment of ovarian cancer

Compounds and methods for enhanced cellular uptake

COMPOSITIONS AND METHODS FOR MODULATION OF IKBKAP SPLICING

Method for promoting angiogenesis, vascularization or vessel repair or for inhibiting tumor angiogenesis

Treatment of disease by modulation of SIRT6

Methods and compositions for reducing viral genome amounts in a target cell

Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2

Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression

Therapeutic nanoparticles and methods of use thereof

Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease

Materials and methods related to modulation of mismatch repair and genomic stability by miR-155

MICRORNAS AND USES THEREOF

MicroRNA compounds and methods for modulating miR-122

Methods and agents to increase therapeutic dystrophin expression in muscle

Conjugated antisense compounds and their use

Methods of inhibiting Alu RNA and therapeutic uses thereof

METHODS AND COMPOSITIONS TO MODULATE ANTIVIRAL AND IMMUNE ACTIVITY RESPONSES

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Compositions and methods for prognosis and treatment of prostate cancer

Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

tRNA derived small RNAs (tsRNAs) involved in cell viability

Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis

Methods and compounds useful in conditions related to repeat expansion

Targeted self-assembly of functionalized carbon nanotubes on tumors

Control of whole body energy homeostasis by microRNA regulation

Inhibitors of metastasis

Synthetic nanostructures including nucleic acids and/or other entities

Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene

Method of controlling coagulation

miRNA-212/132 family as a therapeutic target

Compounds for the treatment of ischemic injury

Composition and methods for modulating cell proliferation and cell death

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of ovarian cancer using a real-time PCR platform

Oligonucleotides for modulation of target RNA activity

Activation of quiescent stem cells

MicroRNA-based methods and assays for osteosarcoma

Therapeutic nanoparticles and methods of use thereof

Micrornas in neurodegenerative disorders

Pharmaceutical anti-angiogenic composition including a MicroRNA-382 inhibitor

MicroRNA inhibitors

Methods for heart regeneration

MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders

Targeting microRNAs for the treatment of liver cancer

Modulators of miR-323-3p for the prevention or treatment of rheumatoid arthritis

Methods and compositions for gene-specific demethylation by DNA methyltransferase (DNMT)-RNA interaction

Methods of modulating MicroRNAs in the treatment of pulmonary arterial hypertension

Methods for diagnosing bone or cardiovascular disorders

Composition for controlling chromogenesis including microRNA

Nucleic acid modulators of glycoprotein VI

Oligonucleotide derivative, oligonucleotide derivative-containing pharmaceutical composition for treatment and pharmaceutical composition for diagnosis, and oligonucleotide derivative for regulation of miRNA function

Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes

MicroRNA compounds and methods for modulating MIR-21 activity

Compositions and methods for treating musculoskeletal diseases and disorders

Methods for treatment of alport syndrome

Differentially expressed microRNA molecules for the treatment and diagnosis of cancer

MiR-33 inhibitors and uses thereof to decrease inflammation

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair

Composition containing antisense oligonucleotide to micro RNA

Antimir-451 for the treatment of polycythemias

Inhibitors of the miR-15 family of micro-RNAs

Oligonucleotide-based inhibitors comprising locked nucleic acid motif

Small interfering RNAS with target-specific seed sequences

UCP1 (thermogenin)—inducing agents for use in the treatment of a disorder of the energy homeostasis

RNA molecules that upregulate insulin production

Methods of inducing insulin production

Compositions and methods for treatment of ovarian cancer

MicroRNA compounds and methods for modulating miR-21 activity

Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138

MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgene

Micro-RNA family that modulates fibrosis and uses thereof

Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG

Micro-RNA family that modulates fibrosis and uses thereof

Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA

Antagonat compositions and methods of use

Methods targeting miR-33 microRNAs for regulating lipid metabolism

Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseases

MicroRNAs that regulate muscle cell proliferation and differentiation

Segmented micro RNA mimetics

Targeted 2′-O-methylation of telomerase non-coding RNA

Micro-RNA family that modulates fibrosis and uses thereof

TREATMENT OF HEPATOCYTE GROWTH FACTOR (HGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO HGF

Method for controlling the amount of gene product, and agent for controlling the amount of gene product

miRNAs involved in the blood brain barrier function

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF BREAST CANCER

LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENT

Antagonists of miRNA-29 expression and their use in the prevention and treatment of aneurysm

Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway

MicroRNA as a cancer progression predictor and its use for treating cancer

AAV-based treatment of cholesterol-related disorders

NKX3-1 saRNA and KLF4 saRNA and uses thereof

Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA

Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA

Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)

Modified oligonucleotides for telomerase inhibition

Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4

Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155

Compositions and methods for inhibiting expression of CD45 gene

Mutator activity induced by microRNA-155 () links inflammation and cancer

Methods and compositions for the detection and treatment of cancer involving miRNAs and miRNA inhibitors and targets

miR-150 for the treatment of blood disorders

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3

SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES

METHOD FOR PREVENTING OR TREATING MEMORY IMPAIRMENT AND PHARMACEUTICAL COMPOSITIONS USEFUL THEREFORE

Methods and compositions to modulate antiviral and immune activity responses

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

Methods and compositions for reducing viral genome amounts in a target cell

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2